These findings demonstrated that RYBP suppresses the malignant phenotype of HCC cells at least partly by modulating the levels of apoptosis- and metastasis-related proteins through both p53-dependent and -independent mechanisms. This evidence concerns the gene RYBP and hepatocellular carcinoma.